Prophylactic antibiotic in patients who undergo cystoscopy with urine sterile: a double blind controlled clinical trial
Phase 3
Completed
- Conditions
- prophylactic antibiotic use in cystoscopy to decrease the incidence of urinary tract infectionRenal and Urogenital - Other renal and urogenital disorders
- Registration Number
- ACTRN12611000750987
- Lead Sponsor
- Herney Garcia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Patients over 18 years, with cystoscopy for any cause, negative urine culture, those who sign in the consent to participate in the study.
Exclusion Criteria
Inability to track or allergy to antibiotic use, or interactions with other drugs, with specific indication for prophylaxis (Pe prosthetic heart valve, heart murmur, prosthetic orthopedic or vascular), taking antibiotics at the time of the procedure, who have a permanent urethral catheter, patients with immunosuppression, spinal cord injury that required catheterization, who were let urethral catheter after the procedure (Exclusions post-randomisation).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the efficacy of prophylactic antibiotic use prior to cystoscopy in outpatients in decreasing the incidence of postprocedure urinary tract infection.<br>Urinary tract infection will be assessed by clinical assessment (asking for lower urinary tract symptoms) and by urine culture taking 3 -5 days after cystoscopy, both of them positive. It will be assessed as a categorical variable yes or no (positive or negative).[Maximum ten days after randomization. <br>While reviewing literature we found that outcomes were assessed during these first ten days, it?s arbitrary but after this day one can find that any etiology other than the procedure can cause a urinary tract infection.]
- Secondary Outcome Measures
Name Time Method